| BPTRX | GFACX | BPTRX / GFACX | |
| Total Expense Ratio | 2.24 | 1.35 | 166% |
| Annual Report Gross Expense Ratio | 2.24 | 1.35 | 166% |
| Fund Existence | 23 years | 25 years | - |
| Gain YTD | -0.475 | 1.530 | -31% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 250 | 800% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 9.75B | 336B | 3% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 21.31 | 6.90 | 309% |
| Returns for 3 years | 113.60 | 47.58 | 239% |
| Returns for 5 years | 42.55 | 10.69 | 398% |
| Returns for 10 years | 731.12 | 95.34 | 767% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RWBEX | 73.78 | -0.18 | -0.24% |
| American Funds Capital World Gr&Inc R2E | |||
| DISYX | 22.24 | -0.11 | -0.49% |
| BNY Mellon International Stock Fund Y | |||
| SCATX | 65.35 | -0.80 | -1.21% |
| Virtus Zevenbergen Innovative Gr Stk I | |||
| ZVNBX | 41.94 | -0.52 | -1.22% |
| Zevenbergen Growth Investor | |||
| CLRYX | 23.01 | -0.33 | -1.41% |
| Columbia Large Cap Growth Opp Inst3 | |||